Third-generation analogues of Guttiferone A

IF 2.5 4区医学 Q3 CHEMISTRY, MEDICINAL Bioorganic & Medicinal Chemistry Letters Pub Date : 2025-03-12 DOI:10.1016/j.bmcl.2025.130186

David Hozain , Kevin Cottet , Yann Fromentin , Annabelle Dugay , Florence Souquet , Elisabeth Mouray , Philippe Grellier , Didier Buisson , Raimundo Gonçalves de Oliveira Junior , Marie-Christine Lallemand

{"title":"Third-generation analogues of Guttiferone A","authors":"David Hozain , Kevin Cottet , Yann Fromentin , Annabelle Dugay , Florence Souquet , Elisabeth Mouray , Philippe Grellier , Didier Buisson , Raimundo Gonçalves de Oliveira Junior , Marie-Christine Lallemand","doi":"10.1016/j.bmcl.2025.130186","DOIUrl":null,"url":null,"abstract":"<div><div>This study introduces third-generation derivatives of guttiferone A, designed to enhance both bioactivity and selectivity against <em>Plasmodium falciparum</em> and <em>Trypanosoma brucei</em>. Following an optimized synthetic route, two dioxolane derivatives of 3,16-oxyguttiferone A were prepared: 14-monodioxolane-3,16-oxyguttiferone A (<strong>3</strong>) and 13,14-bisdioxolane-3,16-oxyguttiferone A (<strong>4</strong>). Biological evaluation revealed compound <strong>3</strong> to be the most effective, with a selectivity index (SI) of 457.1 against <em>Trypanosoma brucei brucei</em> strain and 57.1 against <em>P. falciparum</em>, significantly outperforming its precursors. Compound <strong>4</strong> also demonstrated substantial activity with an SI of 143.8 against <em>T. brucei</em>. These results highlight the potential of targeted structural modifications, particularly monodioxolane substitution, to improve the pharmacological profile of guttiferone A derivatives.</div></div>","PeriodicalId":256,"journal":{"name":"Bioorganic & Medicinal Chemistry Letters","volume":"122 ","pages":"Article 130186"},"PeriodicalIF":2.5000,"publicationDate":"2025-03-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Bioorganic & Medicinal Chemistry Letters","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0960894X25000952","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"CHEMISTRY, MEDICINAL","Score":null,"Total":0}

引用次数: 0

Abstract

This study introduces third-generation derivatives of guttiferone A, designed to enhance both bioactivity and selectivity against Plasmodium falciparum and Trypanosoma brucei. Following an optimized synthetic route, two dioxolane derivatives of 3,16-oxyguttiferone A were prepared: 14-monodioxolane-3,16-oxyguttiferone A (3) and 13,14-bisdioxolane-3,16-oxyguttiferone A (4). Biological evaluation revealed compound 3 to be the most effective, with a selectivity index (SI) of 457.1 against Trypanosoma brucei brucei strain and 57.1 against P. falciparum, significantly outperforming its precursors. Compound 4 also demonstrated substantial activity with an SI of 143.8 against T. brucei. These results highlight the potential of targeted structural modifications, particularly monodioxolane substitution, to improve the pharmacological profile of guttiferone A derivatives.

Abstract Image

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

求助全文

约1分钟内获得全文去求助

来源期刊

Bioorganic & Medicinal Chemistry Letters 医学-医药化学

CiteScore

5.70

自引率

3.70%

发文量

463

审稿时长

27 days

期刊介绍： Bioorganic & Medicinal Chemistry Letters presents preliminary experimental or theoretical research results of outstanding significance and timeliness on all aspects of science at the interface of chemistry and biology and on major advances in drug design and development. The journal publishes articles in the form of communications reporting experimental or theoretical results of special interest, and strives to provide maximum dissemination to a large, international audience.